Next Article in Journal
The Scenario of Clays and Clay Minerals Use in Cosmetics/Dermocosmetics
Next Article in Special Issue
An Overview of Proprietary Vehicles/Bases for Topical Compounding Medicines and Cosmetics
Previous Article in Journal
Microtopography and Barrier Function in Healthy Skin: Differences between Forearm, Cheek and Palm
Previous Article in Special Issue
Current Insights into the Formulation and Delivery of Therapeutic and Cosmeceutical Agents for Aging Skin
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Development of Topical Formulations Containing 20% of Coated and Uncoated Zinc Oxide Nanoparticles: Stability Assessment and Penetration Evaluation by Reflectance Confocal Laser Microscopy

by
Geórgia de Assis Dias Alves
,
Camila Helena Ferreira Cuelho
,
Maria José Vieira Fonseca
* and
Patrícia Maria Berardo Gonçalves Maia Campos
Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-900, São Paulo, Brazil
*
Author to whom correspondence should be addressed.
Cosmetics 2024, 11(1), 6; https://doi.org/10.3390/cosmetics11010006
Submission received: 27 September 2023 / Revised: 12 December 2023 / Accepted: 19 December 2023 / Published: 29 December 2023
(This article belongs to the Special Issue Formulations and Delivery Systems to the Skin)

Abstract

:
The introduction of zinc oxide nanoparticles (ZnOn) in sunscreens solved the issue of poor spreadability of these formulations, which often left a white film on the skin. However, safety concerns have arisen regarding the topical application of ZnOn. Some studies employed commercial sunscreens to address the safety issues of the topical application of ZnOn; however, commercial formulations are often complex and contain a wide range of ingredients that could attenuate the potential damage caused by the ZnOn. Therefore, in this study we aimed to develop a simple stable formulation containing 20% of coated and uncoated ZnOn, characterize the formulations and the nanoparticles, and assess the skin penetration in a Franz diffusion cell. The Feret’s diameter for the uncoated and coated ZnOn was 137 nm and 134 nm, respectively. For the uncoated ZnOn the hydrodynamic size in water was 368 nm and for the coated ZnOn, the average hydrodynamic size in ethyl acetate was 135 nm. The incorporation of ZnOn led to formulations more consistent and easier to spread, as suggested by the lower work of shear and higher values of firmness, cohesiveness, consistency and index of viscosity compared with the vehicle. The stability assessment at 45 °C suggested that the formulations containing the ZnOn were stable for 30 days and the vehicle was stable for 90 days. The assessment of the skin penetration by reflectance confocal laser microscopy indicated that the ZnOn did not permeate into the deepest layers of the skin, but accumulated on the skin furrows, hair and hair follicles.

Graphical Abstract

1. Introduction

Nanotechnology is defined as the “the design, characterization, production and application of structures, devices and systems by controlling shape and size at the nanoscale (<100 nm)” [1].The market currently presents a wide variety of sunscreen formulations because of the increase in the demand for photoprotective agents. Sunscreens can be classified into two: physical sunscreens (inorganic filters) and chemical sunscreens (organic filters). The mechanism of physical sunscreens is to reflect or scatter the UV light and thereby prevent the absorption of UV light into the skin. The decrease in the size of the particles results in less skin whitening and improved UV reflectance and scattering [2]. Titanium dioxide and zinc oxide (ZnO) are the only inorganic filters approved for sunscreen use [3].
Formulations with inorganic filters had a poor cosmetic appearance secondary to poor dispersive qualities, leaving a white or opaque film on the skin and a grainy after-feel. Therefore, these sunscreens had inconsistent and insufficient application of the product, hindering wide acceptance by the public. The texture and aesthetic problems associated with sunscreens containing titanium dioxide and ZnO have largely been solved by the introduction of nanotechnology [3].
Consumers take aesthetics into consideration when choosing a sunscreen, and nanoparticulate formulations are often preferred over microparticulate ones because they are transparent, due to reduced light scattering [4]; however, there is rising concern about the safety implications of these nanomaterials [3].
Some public advocacy groups have questioned the safety of nanoparticulate-based sunscreens, and a 2017 National Sun Protection Survey by Cancer Council Australia found that only 55% of Australians believed it was safe to use sunscreen every day, down from 61% in 2014 [5].
Zinc oxide nanoparticles (ZnOn) have been shown to have more pronounced adverse effects on keratinocytes than titanium dioxide [6]. An example of the toxic effect that nanoparticles may display is the disruption of the mitochondrial function, which leads to the production of reactive oxygen species and activates the oxidative stress-mediated signaling cascade. The production of reactive oxygen species can have detrimental effects on the mitochondrial genome, disturb cell-cycle distribution, and induce oxidative DNA damage and loss of normal cell morphology, ultimately leading to cell death and carcinogenesis [1,6]. In addition, it has been demonstrated that ZnOn possess a genotoxic potential in human epidermal cells, depleting glutathione, catalase and superoxide dismutase [7].
The characterization of the nanoparticles is imperative to correlate it to the biological responses observed [1]. Substances that are too large for penetration such as particles may be entrapped within the hair follicles. Within the hair follicles, the sebaceous gland, the bulge and the hair follicle infundibulum have been recently defined as target sites of interest. The region is the host of the epithelial stem cells providing a high proliferative capacity and multipotency. The hair follicle infundibulum is a further region of interest as the lower infundibulum provides an interrupted barrier with increased permeability [8].
Many studies have focused on the characterization of the nanoparticles [9,10,11] and more recent studies have tried to address the safety issues of the topical application of ZnOn [5,12]. Frequently, the studies solubilize the ZnOn in caprylic/capric triglycerides [5,13,14,15]. Some characterization studies employed commercial sunscreens containing ZnOn for the analysis [16,17]; however, commercial formulations are often complex and contain a wide range of ingredients, like synthetic and natural antioxidants, that could attenuate the potential damage caused by the ZnOn. Therefore, it is more relevant for studies aiming to address the safety issues of the topical application of ZnOn to develop their own formulations. As there are sunscreens in the market with 20% of ZnOn [17], in this study, we aimed to develop a simple stable formulation containing 20% of coated and uncoated ZnOn, characterize the formulations and the nanoparticles, and assess the skin penetration in a Franz diffusion cell.

2. Materials and Methods

2.1. Materials

Chemicals and reagents were obtained from the following commercial sources: cetyl alcohol, glyceryl stearate, PEG-75 stearate, Ceteth-20 and Steareth-20 were acquired from Gattefossé (Lyon, France); lanolin was purchased from Sigma-Aldrich (St. Louis, MO, USA); caprylic/ capric triglyceride was acquired from Croda Chemicals (London, UK); butilenglycol and glycerin were purchased from Fragon (São Paulo, SP, Brazil); benzyl alcohol, xylitol and caprylic acid were acquired from Chemyunion (São Paulo, Brazil); phenoxyethanol was purchased from Sigma-Aldrich (St. Louis, MO, USA); and the uncoated nanoparticles (HP1) and the nanoparticles coated with triethoxycaprylylsilane (Z cote) were purchased from BASF (Ludwigshafen, Germany).

2.2. Characterization of ZnOn

The uncoated and coated (triethoxycaprylylsilane) ZnOn were characterized concerning their zeta potential, size and morphology.

2.2.1. Evaluation of the Nanoparticles’ Size and Morphology Using Microscopy

The morphology of the ZnOn was assessed by scanning electron microscopy (SEM) and transmission electron microscopy (TEM) and the size was assessed by TEM.
Samples for TEM analysis were prepared by dispersing 0.1 g of ZnOn in 10 mL of deionized water. The samples were diluted 8X and then deposited onto the inner meshed surface of carbon-coated TEM Cu-grids. After a few seconds, the excess of the dispersion was removed with a filter paper and the grids were dried overnight in the dark at 25 °C. The JEOL JEM-1000CX II (Tokyo, Japan) transmission electron microscope operating at 100 kV was employed for the analysis. The min (width) and max (length) Feret’s diameter were assessed in approx. 100 particles for each sample with the aid of the ImageJ/Fiji program.
Samples for SEM were prepared by sprinkling approx. 5 mg of ZnOn powder over adhesive conducting tape covering an SEM metal stub. The nanoparticles were coated with gold using a BALTEC SCD 050 sputter coater. Sputtering was conducted under vacuum while the passing gas was argon. The coating deposition time was 120 s at a plate current of 100 mA, giving a coating thickness of approximately 10 nm. The JEOL JSM 6610LV (Tokyo, Japan) scanning electron microscope operating at 20 kV was employed for the analysis.

2.2.2. Determination of the Hydrodynamic Size by Dynamic Light Scattering (DLS)

The z-average hydrodynamic particle diameter was obtained using a Zetasizer Nano ZS (Malvern Panalytical) with a detection of 90°. Disposable polystyrene cuvettes were used for determinations using water as dispersant and the DIP cell was used for the determinations using ethyl acetate. The determinations were a modification of previously reported protocols [10,18] at a temperature of 25 °C. The following dilutions were tested aiming to optimize the detection: coated ZnOn were diluted in ethyl acetate (2 mg/10 mL; diluted 10 fold), uncoated ZnOn were diluted in deionized water (2 mg/40 mL; 1 h ultrasonic bath or 10 mg/6 mL deionized water; ultrasonic bath for 30 min) and the coated ZnOn were diluted in deionized water (2 mg/40 mL; 1 h ultrasonic bath or 10 mg/3 mL deionized water; ultrasonic bath for 30 min, diluted 2 times).

2.2.3. Determination of the Zeta Potential

The zetapotential was assessed by laser Doppler electrophoresis using a Zetasizer Nano ZS (Malvern Panalytical). The uncoated ZnOn were dispersed in deionized water at 10 mg/6 mL following a 20-fold dilution and the coated ZnOn were dispersed in deionized water at 10 mg/3 mL following a 2-fold dilution. The measurements were calculated by the Helmholtz–Smoluchowski equation.

2.3. Development and Characterization of the Topical Formulations

The formulations were prepared by heating the oil phase at 50 °C and the aqueous phase at 75 °C following spontaneous emulsification by adding the oil phase in the aqueous phase and stirring for 40 min at 800 rpm. The coated ZnOn were added in the oil phase and the uncoated ZnOn were added in the aqueous phase. Table 1 presents the composition of the topical formulations. Preservative 1 was chosen as a replacement for the controversial preservatives and chemically it consists of a 100% biodegradable ester of vegetal origin. Preservative 2 was added to broaden the effectiveness against fungi. The formulations were characterized by their texture, hardness and zeta potential.
Self emulsifying base: cetyl alcohol, glyceryl stearate, PEG-75 stearate, Ceteth-20 andSteareth-20. Preservative 1: benzyl alcohol, xylitol and caprylic acid. Preservative 2: phenoxyethanol. Coated ZnOn: ZnOn + triethoxycaprylylsilane.

2.3.1. Determination of Zeta Potential of the Formulations

The formulations were suspended in water (50 mg/3 mL, followed by 50× dilution) and the zeta potential was evaluated by laser Doppler electrophoresis in the Zetasizer Nano ZS (Malvern Panalytical).

2.3.2. Texture Analyses

The texture analyses were performed using a TA.XT plus TextureAnalyzer (Stable Microsystems, United Kingdom) equipped with two probes: TTC Spreadability rig HDP/SR and Back Extrusion rig A/BE 35 mm at room temperature. The work of shear was obtained from the area under the positive curve [19]. The probe conditions were return distance 25 mm, return speed 20 mm s−1 and contact force 30 g. The firmness was obtained from the maximum value of the positive curve, the consistency from the area under the positive curve, the cohesiveness from the maximum value of the negative curve and the index of viscosity from the area under the negative curve [19]. For these parameters, the formulations were loaded in containers with 50 mm of diameter (125 mL). The return distance used was 100 mm, the return speed was 20 mm s−1 and the contact force was 30 g. The data obtained from the negative curve were analyzed as absolute values.

2.3.3. Hardness Analysis

The texture analysis was performed using a TA.XT plus TextureAnalyzer (Stable Microsystems, UK). The method was conducted under the following conditions: pre-test speed of 2 mm/s; test speed of 1 mm/s; 1% of rupture test distance; force of 0.01 kg; automatic trigger force of 0.015 kg and platform distance of 10 mm. The following parameters were calculated as mean of five measurements: hardness (g); compressibility (mm2); tackiness (g) and elasticity (cm).

2.4. Stability Evaluation

The stability study evaluated the physical, functional and structural stability of the formulations kept at 45 °C ± 2 °C/75% RH ± 5% RH for 90 days. The analyses were performed at 0, 7, 15, 30, 60, and 90 days.

2.4.1. Functional Stability

The functional stability was evaluated spectroscopically by the ability of the formulations to reflect or disperse the radiation. The formulations were applied (0.2 mg/cm2) onto the surface of the quartz cuvettes. The cuvettes were kept in the dark for 15 min. Then, the reading solution was added to the cuvettes and the reflected or dispersed light was read from 280 to 400 nm. The reading solution was prepared by adding 1.25 mL of a 0.01% quercetin solution and 1 mL of a 6% aluminum chloride solution to 22.5 mL of ethanol. The area under the curve was calculated in the GraphPad Prism® software 8.

2.4.2. Structural Stability

The microscopic analyses were performed on the Zeiss Axiovert 40 inverted microscope and the images were processed in the Axiovision Rel. 4.8.2 software (Carl Zeiss, Jena, Germany). The hydrodynamic size of the formulations (50 mg/3 mL, followed by 50X dilution) was evaluated by DLS in polystyrene cuvettes with the aid of Zetasizer Nano ZS (Malvern Panalytical) with a detection angle of 90°.

2.4.3. Physical Stability—Rheological Assessment

The rheological behavior was assessed at 25 °C on the Brookfield DV-III digital cone/plate rheometer with a 4 mm GAP and the CP25 spindle. The total analysis time was 80 s for the ascending and descending curves and the rotation speed varied from 0 to 4 rpm. The RHEOCALC software version V 1.01 was used to obtain the apparent viscosity values. The flow index, thixotropy (hysteresis area) and consistency index were calculated using the Origin 8.0 software.

2.5. Assessment of the Microbiological Quality and Antimicrobial Efficiency Testing

The microbiological quality of the vehicle and the formulations containing ZnOn was assessed in accordance with the microbiological test described in U.S. Pharmacopeia [20].
The efficacy of the preservatives in the formulations was evaluated against Staphylococcus aureus (ATCC 6538), Pseudomonas aeruginosa (ATCC 9027) and Escherichia coli (ATCC 10536) and Candida albicans (ATCC 11006) according to the procedure and acceptability criteria described in the U.S. Pharmacopeia [20].

2.6. Skin penetration Assessment

The skin penetration assessment was carried out in a Franz-type diffusion cell as follows: the receptor compartment was filled with 20 mM isotonic phosphate buffer (pH 7.4) with 0.5% (v/v) polyoxyethylene (20) sorbitan monolaurate. The porcine skin was clamped between the donor and the receptor chambers with the stratum corneum facing upward and the dermis in contact with the receptor medium. Samples of 2 mg/cm2 of the formulations were placed on the epidermis in the donor chamber. The diffusion cells were incubated at 32 °C, and the receptor medium was stirred with a rotating Teflon-coated magnet for 12 h. The skins were analyzed qualitatively using the Reflectance Confocal Laser Microscope (RCM), Vivascope® 150 (Lucid, Rochester, NY, USA).

2.7. Statistical Analysis

The normality was evaluated with the aid of the Origin 8.0 software and the statistical analyses were carried out on GraphPad Prism® software 8. The normally distributed data underwent the analysis of variance followed by the Bonferroni test. The data that was not drawn from a normal distribution underwent the Kruskal–Wallis test followed by the Dunn’s multiple comparison test. The values of p < 0.05 were statistically indicative of difference between the data in question under a 95% confidence interval.

3. Results and Discussion

3.1. Characterization of ZnOn

The International Organization for Standardization emphasizes that the physicochemical characterization of nanomaterials is critical for the identification of test materials before toxicological assessment [21]. Therefore, the characterization of ZnOn was carried out before the development of the topical formulation.
The SEM evaluation showed that the ZnOn powders were highly agglomerated and aggregated, as visible in the micrographs (Figure 1A,B). The assessment of the morphology presented nanoparticles with rod, cubic, tetragonal, hexagonal and orthorhombic morphologies for both samples. In some cases, nanoparticles may enter the cell after binding to the receptor target. Once bound, several factors can dictate the behavior of nanomaterials at the nano-bio interface, e.g., the nanoparticle’s shape may influence uptake into cells. For nanoparticles with a size larger than 100 nm, rods show the highest uptake, followed by spheres, cylinders, and cubes [1]. In this study a high incidence of rod-shaped nanoparticles in the coated and uncoated ZnOn was observed; therefore, the cell uptake could be increased.
The assessment of the size of the uncoated (Figure 1C) and coated (Figure 1D) ZnOn by TEM varied from 55 to 413 nm and from 39 to 456 nm, respectively. For titanium dioxide, which is another inorganic filter, the nanoparticles with 30 nm have been demonstrated to induce the highest generation of reactive oxygen species [1]. The presence of small-sized nanoparticles in the uncoated and coated samples could result in the cell uptake of these nanoparticles, which could lead to cell damage.
The average of the max Feret’s diameter for the uncoated and coated ZnOn was 137 nm and 134 nm, respectively (Figure 2A,B). The ratio of max per min Feret’s diameter varied from 1.1 to 9.9 and from 1.1. to 5.6 for the coated and uncoated ZnOn, respectively. For the coated ZnOn and the uncoated ZnOn diluted less than twice, the size of all the coated nanoparticles was equal to or lower than 200 nm, while 94.7% of the uncovered nanoparticles exhibited a size smaller than 200 nm. However, when the coated and uncoated nanoparticles were diluted more than twice, 81.8% and 75.7% of the uncoated and coated nanoparticles, respectively, were greater than 100 nm in size, which is characteristic of cubic and short rod-shaped nanoparticles [18].
A previous study employed the protocol used in this study for the hydrodynamic particle size determination using DLS (10 mg/3 mL deionized water; ultrasonic bath for 10 s). They obtained an average hydrodynamic size and PDI of 340 nm, 192 nm and 0.2, 0.2 for the uncoated and coated ZnOn, respectively [10]. In this study, the average hydrodynamic size and PDI for the coated ZnOn under these conditions were 371 nm and 0.295, respectively. The hydrodynamic size decreased to 282 nm when the samples were kept in an ultrasonic bath for 1 h; however, the PDI increased to 0.332.
For the uncoated ZnOn, 3 mL of deionized water was not enough to suspend 10 mg of the nanoparticles; therefore, the samples were suspended in 6 mL of deionized water and were diluted 2-fold to achieve a hydrodynamic size and PDI of 368 and 0.259, respectively (Figure 2C). This concentration was the best result we obtained for the uncoated ZnOn; however, the mean hydrodynamic size is considerably higher than the mean Feret’s diameter (137 nm), which suggests that DLS is not an appropriate methodology to assess the size of the uncoated ZnOn under the tested conditions.
Another study encountered better results with the samples in the concentration 50 mg/L [18]. Their results of hydrodynamic sizes and PDI for the uncoated and coated ZnOn were 275 nm, 253 nm and 0.145, 0.401, respectively. We tested this concentration (2 mg/40 mL; 1 h ultrasonic bath) and obtained similar results of hydrodynamic size and PDI for the coated ZnOn, respectively, 258 nm and 0.238. However, for the uncoated ZnOn the hydrodynamic size was remarkably higher, 962 nm (PDI: 0.258), which indicates substantial agglomeration.
The hydrodynamic diameter found for the coated and uncoated ZnOn was larger than the Feret’s diameters measured by TEM. That is often the case for several nanoparticles because when a dispersed particle moves through a liquid medium an electric dipole layer, which is often thin, adheres to its surface. Thus, the hydrodynamic diameter gives us information about the solvent layer attached to the particle as it moves under the influence of Brownian motion [22].
Aiming to reduce the agglomeration, organic solvents were tested in order to improve the solubilization of the nanoparticles. The coated ZnOn solubilized exceedingly well in ethyl acetate. The sample was visually stable with no signs of sedimentation, which suggests that the particles were undergoing Brownian diffusional motion throughout the measurement.
The average hydrodynamic size and the PDI for the coated ZnOn in ethyl acetate (2 mg/10 mL; diluted 10-fold) was 135 and 0.149, respectively (Figure 2D). Although the PDI indicates a polydisperse sample (values smaller than about 0.04 are considered monodisperse) [18], this could be a characteristic of the sample, rather than an indication of the poor applicability of the technique. The size found by DLS was compatible to the Feret’s diameter (134 nm), which suggests that in contrast to what has previously been believed [10,18], DLS is an appropriate technique for measuring the mean hydrodynamic diameter of the coated ZnOn if the nanoparticles are suspended in ethyl acetate. DLS is a technique widely used to assess hydrodynamic diameters of nanoparticle dispersions; therefore, these results are important to substantiate the use of this technique for the coated ZnOn.
The zeta potential for the coated (10 mg/3 mL; diluted 2-fold) and uncoated (10 mg/6 mL; diluted 20-fold) ZnOn in deionized water was −19.5. and 21.3, respectively. It has been discussed that the smallest agglomerate size is achieved when the nanoparticle displays a strongly charged surface. The intense charge on the surface increases the charge–charge repulsions between the particles, thus maintaining a more stable and monodispersed suspension [23]. However, for the tested ZnOn, the zeta potential was high and there was still significant agglomeration. The results for the zeta potential are in agreement with other studies that show that uncoated zinc oxide nanoparticles often exhibit positive zeta potential, while the nanoparticles coated with triethoxycaprylylsilane exhibit negative zeta potential [10,18,23]. This indicates that the coating material may be associated with the shift in the zeta potential. Moreover, it has been suggested that positively charged nanoparticles are taken by the cells at a faster rate than nanoparticles with a neutral or negative charge [1]. This suggests that the skin toxicity may be different for the two ZnOn tested.
Furthermore, the zeta potential of the coated ZnOn in ethyl acetate (2 mg/10 mL; diluted 10-fold) was 0.0657. It has been suggested that a hypothetical model nanoparticle exhibits the largest agglomerate size at the point where its zeta potential is 0 mV [23]. However, in ethyl acetate the zeta potential was close to zero and there was no significant agglomeration, which is possibly related to the low conductivity of the non-aqueous dispersant.

3.2. Development and Characterization of the Topical Formulations

Several formulations were tested aiming to incorporate 20% of ZnOn in the formulations. Initially the formulations were tested in water instead of buffer to avoid instability due to incompatibility. The first formulations were developed based on a previous study [24] and the main ingredients were ceteareth-20, cetearyl alcohol and different polymers, besides emollients and humectants. Formulations employing a non-ionic self-emulsifying base (cetearyl alcohol, and a polyoxyethylene derivative of a fatty acid ester of sorbitan) and an anionic self emulsifying base (mineral oil, isopropyl palmitate, Trilaureth-4 Phosphate, rapseed oil sorbitol esters and ammonium acryloyldimethyltaurate/VP copolymer) were also tested. Initially, in the development of the formulation, the dispersed nanoparticles in caprylic/capric triglycerides were incorporated at 20% into the formulation, after the emulsification of the oil phase in the aqueous phase. The addition of the ZnO nanoparticle dispersion after the emulsification of the two phases led to the immediate separation of these phases. Therefore, the ZnOn were then incorporated either in the aqueous (uncoated ZnOn) or oil phases (coated ZnOn). None of the above-mentioned formulations were stable and in up to 5 min they exhibited a distinctive appearance: the formulations presented a characteristic white color and were fragmented in small granules with medium consistency, suggesting the consumption of the water.
The formulation with the non-ionic self-emulsifying base presented in Table 1 resulted in an initially stable formulation. The formulation was firstly prepared in water and latter prepared in buffer to avoid pH variation. It was observed that the formulation prepared in buffer was more consistent than the one prepared in water. Moreover, it was observed that the addition of the ZnOn increased the pH considerably. Using a buffer with the pH of 3.5, the vehicle pH was 4, while the pH of the formulations containing ZnOn was 8.0. Therefore, the formulations were prepared in buffer pH 5.0, which resulted in a vehicle with pH 5.5 and formulations with pH 8.0. The pH of the formulations containing ZnOn decreased to approximately 6.1.

3.2.1. Characterization of the Topical Formulations

The zeta potential of the vehicle and the formulations containing the uncoated and coated ZnOn were −22 mV, −13 mV and −8 mV, respectively. It was observed that the incorporation of ZnOn decreased the zeta potential, which could destabilize the formulation.
The texture parameters showed that the work of shear of the formulations containing the ZnOn were not significantly different and were smaller than the vehicle (Figure 3). The work of shear represents the total amount of force required to perform the shear process during the texture test [25] and it is inversely related to the spreadability of the sample [26]. Therefore, the formulations containing the ZnOn presented a lower work of shear, which indicates that the incorporation of the nanoparticles in the vehicle led to formulations which were easier to spread.
The visual evaluation of the formulations suggested that the incorporation of ZnOn led to more consistent formulations, which was confirmed by the higher values of firmness, cohesiveness, consistency and index of viscosity for the formulations containing ZnOn compared with the vehicle (Figure 3). Firmness represents the maximum force during the probe penetration to shear in texture test [25]. This suggests that during the test, the formulations containing ZnOn endured the application of higher force than the vehicle, but less force was required for the formulations containing the ZnOn to be spread. In addition, the formulation containing the coated ZnOn presented higher texture values than the formulation containing the uncoated ZnOn but the work of shear was not statistically different. This indicates that the increase in firmness, cohesiveness, consistency and viscosity index for the formulation containing the coated ZnOn was not substantial enough to affect the spreadability of the formulation.
Thixotropy is defined as the continuous decrease in viscosity with time when flow is applied to a sample that has been previously at rest and the subsequent recovery of viscosity in time when the flow is discontinued [27]. Therefore, topical formulations with a thixotropic behavior are highly desired because they deform during the application. It is interesting to obtain a thixotropy value that is not too high so that the product does not run on the skin after application, but not a very low value, since it can result in low spreadability and non-uniform distribution on the skin [28].
The formulation containing the coated ZnOn presented significantly higher thixotropy than the vehicle and the formulation containing the uncoated ZnOn (Figure 4). Although the work of shear was significantly different between the formulations containing ZnOn, the thixotropy suggests that the formulation containing the coated ZnOn could have better spreadability, which reinforces the results of the texture parameters. In addition, the texture and thixotropy results suggest that the coating of the nanoparticles with triethoxycaprilylsilane may have had a positive impact on the texture and spreadability of the formulation.
Elasticity is the ratio of the duration of contact with the sample between the second and first compression, which indicates the rate at which a deformed material returns to its undeformed condition after the deforming force is removed [29]. As shown in Figure 4, there was no change in elasticity between the formulations developed, and the value found suggests that the formulations exhibit low elasticity compared with other topical formulations [30].
Hardness is the maximum force applied to the sample during the first compression cycle [29] and the compressibility corresponds to the area [30]. The stickiness is given by the force at the maximum point in the second compression cycle. Thus, a stickier sample will require a greater force for the probe to be removed [25]. The hardness, stickiness and compressibility of the formulations containing the ZnOn were higher than the vehicle (Figure 4). For these parameters, there was no significant difference between the formulations containing the ZnOn. This suggests that the incorporation of the nanoparticles led to a physical alteration in the formulation, but coating the nanoparticles with trietoxicaprilylsilane did not influence the evaluated parameters.

3.2.2. Stability Evaluation

Functional Stability

The functional stability was evaluated spectroscopically by the ability of the formulations to reflect radiation. Figure 5 shows the absorption spectrum of the formulations developed and suggests that the absorption capacity of the UVA/B radiation of the formulation containing the coated ZnOn is higher than the formulation containing the uncoated ZnOn. The absorption capacity of UVA/B radiation by the vehicle of the formulations was very similar to the control, indicating that the components of the vehicle do not absorb this radiation. The coated and uncoated ZnO nanoparticles are responsible for the absorption.
The area under the curve of the samples at 0, 15, 30, 60 and 90 days was calculated and it was not possible to observe a change in the functional stability of the samples, since the area under the curve ranged from 61.1 to 58.9, from 39.7 to 42.8 and from 3.2 to 4.1 for formulations containing coated, uncoated and vehicle nanoparticles at 0 and 90 days, respectively. Thus, apparently the ZnOn did not undergo any process of degradation that resulted in loss of activity.

Structural Stability

The microscopic evaluation suggested the tendency of the nanoparticles to agglomerate in the formulations. Nanoparticles have strong crystal attractions which form clustered, tightly bound aggregates. Aggregates are the smallest particles which can be found in sunscreen formulations, because the forces required to break apart aggregates are far greater than those forces encountered during production or during application onto the skin [3]. The instability signs were defined as the presence of agglomerates with different characteristics than the native agglomerates of the formulation. Figure 6 shows micrographs at 0 and 90 days. It was not possible to observe any clear signs of instability for the vehicle during the study time (Figure 6A,B). The formulations containing the uncoated ZnOn showed instability signs at day 60. The circled area points out the structures that appeared at day 60 (Figure 6D). For the formulations containing the coated ZnOn, signs of instability were detected at day 90 (white arrows in Figure 6F, which are more clearly presented in Figure 7). The instability signs observed for the formulation containing the coated ZnOn had a crystalline appearance and were less evident than for the formulation containing the uncoated ZnOn.
For the size evaluation by DLS, the vehicle presented a hydrodynamic size of 309.4 nm (PDI of 0.400) at time 0, indicating the presence of polydisperse nanoparticulate material in the formulation. At day 15, the size decreased to 192.9 nm (PDI of 0.308) and was maintained until the end of the study. The formulation containing the uncoated ZnOn presented a hydrodynamic size of 534 nm (PDI of 0.500) at time 0. At day 7, the size decreased to 439.2 nm (PDI: 0.417) and was maintained until the end of the study. The formulation containing the coated ZnOn presented a hydrodynamic size of 307 nm (PDI of 0.324) at time 0. At day 7, the size increased to 389 (PDI of 0.467) and was maintained until the end of the study. Evaluation of the hydrodynamic size of the formulations indicated a reorganization of the vehicle molecules from time 0 to 15 days. The same was observed for the formulations containing the ZnOn from 0 to 7 days. The DLS technique resulted in a satisfactory characterization of the formulations, but it was not able to detect instability signs possibly because the formulations were polydisperse. Moreover, the vehicle also presented nanoparticles, which might have interfered in the size determination of the ZnOn in the formulations.

Physical Stability—Rheological Assessment

At day 60, an aqueous build up was observed on the surface of the formulation containing the uncoated ZnOn, which is suggestive of instability. The rheological analysis confirmed the instability of the formulation and, due to the lack of homogeneity, it was not possible to obtain reproducible rheograms. Thus, Figure 8 shows the rheograms of the vehicle and the formulation containing the coated ZnOn at 0, 7, 15, 30, 60 and 90 days, while the rheograms of the formulation containing the uncoated ZnOn are presented only at 0, 7, 15 and 30 days.
The rheological characterization of the formulations and the evaluation of the viscosity, flow index, consistency index and thixotropy allow a better understanding of the physicochemical nature of the formulations in the development phase. In addition, it allows the control of the quality of raw materials and finished products, to evaluate the effect of the consistency of the product on the release and skin penetration, besides contributing to the prediction of the shelf life of the product [31]. The formulations did not show significant variations in the flow index during the study time, and presented a flow index lower than 1, which indicates pseudoplastic behavior. Pseudoplastic materials exhibit non-Newtonian flow and are characterized by the reduction in viscosity with the increase in the applied force [32]. This behavior is the most common in cosmetic formulations and presents a characteristic film formation on the surface of the skin [33].
Figure 8 represents the rheograms of the formulations and Figure 9 shows the variations in the hysteresis area, consistency index and minimum apparent viscosity for 90 days. For the vehicle, there was no significant variation in the parameters for 90 days. For the formulation containing the uncoated ZnOn, there was no significant difference in the parameters for 30 days. At 60 and 90 days, it was not possible to perform the rheological analysis due to the instability of the formulation, which compromised the reproducibility of the results. For the formulation containing the coated ZnOn, there was no significant difference in the parameters for 30 days. At 60 and 90 days there was a decrease in the hysteresis area, minimum apparent viscosity and consistency index compared to time 0. Therefore, the formulations and the vehicle were considered stable for 30 and 90 days, respectively.

3.3. Assessment of the Microbiological Quality and Antimicrobial Efficiency Testing

In order to avoid skin sensitization by the preservatives, no controversial preservatives were used. Instead, a biodegradable ester of vegetal origin was employed at its lower concentration of use. Therefore, it was imperative to assess the effectiveness of the preservatives used.
The total amount of aerobic microorganisms and yeasts and molds was assessed on the formulations on Trypticase soy agar and Sabouraud agar plates, respectively. An absence of colony-forming units was found on the Trypticase soy agar and Sabouraud agar plates, indicating the absence of microbial contamination in one gram of the formulations.
The efficiency of the preservatives, a biodegradable ester of vegetal origin and phenoxyethanol, were evaluated against S. aureus, E. coli, P. aeruginosa and C. albicans. The preservatives eliminated the microbial load added to the formulations in 14 days and the absence of growth was maintained until day 28. These results are in accordance with the acceptance criteria for preservatives established by the U.S. Pharmacopeia and indicate that the preservatives used were efficient in eliminating the microbial load that could be introduced by the consumer. Figure 10 shows that the antimicrobial efficiency of the preservative system was similar for the vehicle and the formulations containing the ZnOn. This suggests that the ZnOn did not adsorb the preservatives or the microorganisms. If the ZnOn had adsorbed the preservatives, the antimicrobial efficiency of the formulations would be lower than the vehicle and the opposite would be observed if the ZnOn had adsorbed the microorganisms.

3.4. Penetration Assessment

Reflectance Confocal Microscopy (RCM) imaging is a non-invasive technique that shows nuclear and cellular-level morphology. Imaging is based on the detection of singly backscattered photons from the optical section and contrast is due to the relative variations in refractive indices and sizes of organelles and microstructure [34].
Figure 11 shows RCM images of the stratum corneum (A1, B1, C1, D1), granular layer (A2, B2, C2, D2) and hair/hair follicles (A3, B3, C3, D3) of porcine skin treated with the vehicle (B) and the formulations containing the coated (C) and uncoated (D) ZnOn. Higher reflectance in the stratum corneum was observed for the skin treated with the formulations containing the ZnOn, which suggests the presence of the ZnOn. The formulation containing the coated ZnOn evidently accumulated on the skin furrows (Figure 11, white arrows), which was not observed for the formulation containing the uncoated ZnOn.
Although the uncoated ZnOn did not show major accumulation on the skin furrows, the coated and uncoated ZnOn accumulated around the hair and in the hair follicles (Figure 11C3,D3). Whereas for the vehicle and the non treated skin, it was possible to observe the hair up until the medulla (Figure 11A3,B3, white arrows), a thick coat of nanoparticles covered the hair, which prevented the visualization of the inner part of the hair. Though the penetration assessment was carried out in porcine skin, the size of the porcine hair follicles corresponds approximately to the size of human terminal hair follicles. Therefore, results can be expected to be similar in human terminal hair follicles [35].
The increased reflectance in the skin treated with the formulation containing the coated ZnOn was observed only in the skin furrows and hair follicles, but not within the keratinocytes, which could suggest that the nanoparticles did not enter the cells. In addition, the honeycomb pattern was maintained in the skins treated with the formulations and there were no signs of inflammation in 12 h. However, it is possible that the penetration was underestimated for the skins treated with the formulation containing the uncoated ZnOn. These nanoparticles did not have a protective cover and the zinc ions could have been liberated from the ZnOn accumulated on the stratum corneum, promoted by the hydrolysis of ZnOn to Zn2+ at the normal acidic pH of the skin [5].
The penetration of substances applied topically to the skin occurs by diffusion through the lipid layer around the corneocytes. However, in recent decades some researchers have shown that hair follicles play an important role in the penetration of substances through the stratum corneum, in addition to the lipid layer. In the last decade, investigations have shown that the hair follicles perform a significant part in skin penetration [36]. Moreover, studies have shown that nanoparticles accumulated in hair follicles can remain in the follicles for up to 10 days until gradually cleared by sebum flow [36]. Hair follicle stem cells play vital roles in the hair cycle and skin regeneration after injury. ZnOn accumulated in hair follicles have been shown to impair the transcriptional activity of genes important for hair follicle stem cell differentiation and increased the expression of apoptosis-related proteins. The pathways involved in cellular communication, cell differentiation, and RNA biosynthesis were also altered [12]. A recent study using a Franz diffusion cell showed that ZnOn accumulated on the skin surface and within the skin furrows but did not enter or cause cellular toxicity in the viable epidermis; however. zinc ion concentrations in the viable epidermis of excised human skin were slightly elevated [5].
The protocol used in this study employed one application of the formulations. The formulations accumulated on the skin furrows, hair and hair follicles; however, it is evident that repeated daily application of ZnOn may lead to an increase in the concentration of zinc species in the skin [5]. Therefore, to clarify the safety concerns, biochemical markers of oxidative stress and inflammation should be assessed after prolonged use of formulations containing ZnOn.

4. Conclusions

“The results of the evaluation of formulations C and UC and the vehicle by zeta potential measurement showed lower potential values than the vehicle. Texturometer analysis showed that the formulations with ZnOn nanoparticles coated and uncoated had higher firmness, cohesiveness, consistency and viscosity index values than the vehicle, but the spreadability values were similar to the vehicle. These results were confirmed by the rheological analysis data, which showed pseudoplastic behavior of both formulations and the vehicle. The formulations added with coated and uncoated ZnOn nanoparticles showed similar physicochemical properties.
Evaluation of the physicochemical stability of the formulations showed that both formulations have a decrease in their rheological properties, consistency index, apparent viscosity and hysteresis area, when stored at 45 °C during 7, 15, 30, 60 and 90 days. The formulation added with coated nanoparticle ZnOn showed a greater ability to absorb UVA/UVB radiation when compared to the formulation with uncoated nanoparticles. Therefore, the absorbances observed for the formulations were due to the ZnOn nanoparticles, indicating that the raw materials have the functional capacity to absorb UVA/UVB radiation. The coated ZnOn nanoparticles incorporated into the formulation accumulated in the furrows and hair follicles, but were not found inside the keratinocytes, which suggests that they do not penetrate in the viable epidermis”.

Author Contributions

Conceptualization, M.J.V.F. and P.M.B.G.M.C.; methodology, G.d.A.D.A. and C.H.F.C.; validation, G.d.A.D.A., M.J.V.F. and P.M.B.G.M.C.; formal analysis, G.d.A.D.A. and C.H.F.C.; investigation, G.d.A.D.A., M.J.V.F. and P.M.B.G.M.C.; resources, P.M.B.G.M.C.; data curation, G.d.A.D.A.; writing— original draft preparation, G.d.A.D.A. and C.H.F.C.; writing—review and editing, M.J.V.F. and P.M.B.G.M.C.; visualization, M.J.V.F.; supervision, P.M.B.G.M.C.; project administration, M.J.V.F. and P.M.B.G.M.C.; funding acquisition, M.J.V.F. All authors have read and agreed to the published version of the manuscript.

Funding

The authors are grateful to the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)—Finance Code 001.

Data Availability Statement

The data that support the findings of this study are available upon request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Acknowledgments

The authors are grateful to the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)and the Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP). This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001. The authors are thankful to Malvern Panalytical, especially to Henrique Kajiyama and Wagner Vitalis for providing the DIP CELL kit.

Conflicts of Interest

The authors have no conflicts of interest to declare.

Abbreviations

ZnOn: Zinc Oxide nanoparticles.

References

  1. Albanese, A.; Tang, P.S.; Chan, W.C. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 2012, 14, 1–16. [Google Scholar] [CrossRef] [PubMed]
  2. Jose, J.; Netto, G. Role of solid lipid nanoparticles as photoprotective agents in cosmetics. J. Cosmet. Dermatol. 2019, 18, 315–321. [Google Scholar] [CrossRef] [PubMed]
  3. Chen, L.L.; Wang, S.Q. Chapter 18—Nanotechnology in Photoprotection. In Nanoscience in Dermatology; Hamblin, M.R., Avci, P., Prow, T.W., Eds.; Academic Press: Boston, MA, USA, 2016; pp. 229–236. [Google Scholar]
  4. Cross, S.E.; Innes, B.; Roberts, M.S.; Tsuzuki, T.; Robertson, T.A.; McCormick, P. Human Skin Penetration of Sunscreen Nanoparticles: In-vitro Assessment of a Novel Micronized Zinc Oxide Formulation. Skin. Pharmacol. Physiol. 2007, 20, 148–154. [Google Scholar] [CrossRef] [PubMed]
  5. Mohammed, Y.H.; Holmes, A.; Haridass, I.N.; Sanchez, W.Y.; Studier, H.; Grice, J.E.; Benson, H.A.E.; Roberts, M.S. Support for the Safe Use of Zinc Oxide Nanoparticle Sunscreens: Lack of Skin Penetration or Cellular Toxicity after Repeated Application in Volunteers. J. Investig. Dermatol. 2019, 139, 308–315. [Google Scholar] [CrossRef]
  6. Kocbek, P.; Teskač, K.; Kreft, M.E.; Kristl, J. Toxicological Aspects of Long-Term Treatment of Keratinocytes with ZnO and TiO2 Nanoparticles. Small 2010, 6, 1908–1917. [Google Scholar] [CrossRef]
  7. Sharma, V.; Shukla, R.K.; Saxena, N.; Parmar, D.; Das, M.; Dhawan, A. DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Toxicol. Lett. 2009, 185, 211–218. [Google Scholar] [CrossRef]
  8. Patzelt, A.; Knorr, F.; Blume-Peytavi, U.; Sterry, W.; Lademann, J. Hair follicles, their disorders and their opportunities. Drug Discov. Today Dis. Mech. 2008, 5, e173–e181. [Google Scholar] [CrossRef]
  9. Lu, J.; Guo, J.H.; Tu, X.L.; Zhang, C.; Zhao, M.; Zhang, Q.W.; Gao, F.H. Tiron Inhibits UVB-induced AP-1 binding sites transcriptional activation on MMP-1 and MMP-3 promoters by MAPK signaling pathway in human dermal fibroblasts. PLoS ONE 2016, 11, e0159998. [Google Scholar] [CrossRef]
  10. Yin, H.; Coleman, V.A.; Casey, P.S.; Angel, B.; Catchpoole, H.J.; Waddington, L.; McCall, M.J. A comparative study of the physical and chemical properties of nano-sized ZnO particles from multiple batches of three commercial products. J. Nanoparticle Res. 2015, 17, 96. [Google Scholar] [CrossRef]
  11. Singh, M.; Kapoor, A.; Bhatnagar, A. Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls. Chemico-Biol. Interact. 2015, 234 (Suppl. C), 261–273. [Google Scholar] [CrossRef]
  12. Ge, W.; Zhao, Y.; Lai, F.-N.; Liu, J.-C.; Sun, Y.-C.; Wang, J.-J.; Cheng, S.-F.; Zhang, X.-F.; Sun, L.-L.; Li, L.; et al. Cutaneous applied nano-ZnO reduce the ability of hair follicle stem cells to differentiate. Nanotoxicology 2017, 11, 465–474. [Google Scholar] [CrossRef] [PubMed]
  13. Leite-Silva, V.R.; Liu, D.C.; Sanchez, W.Y.; Studier, H.; Mohammed, Y.H.; Holmes, A.; Becker, W.; Grice, J.E.; Benson, H.A.; Roberts, M.S. Effect of flexing and massage on in vivo human skin penetration and toxicity of zinc oxide nanoparticles. Nanomedicine 2016, 11, 1193–1205. [Google Scholar] [CrossRef] [PubMed]
  14. Leite-Silva, V.; Sanchez, W.; Studier, H.; Liu, D.; Mohammed, Y.; Holmes, A.; Ryan, E.; Haridass, I.; Chandrasekaran, N.; Becker, W.; et al. Human skin penetration and local effects of topical nano zinc oxide after occlusion and barrier impairment. Eur. J. Pharm. Biopharm. 2016, 104, 140–147. [Google Scholar] [CrossRef] [PubMed]
  15. Holmes, A.M.; Song, Z.; Moghimi, H.R.; Roberts, M.S. Relative Penetration of Zinc Oxide and Zinc Ions into Human Skin after Application of Different Zinc Oxide Formulations. ACS Nano 2016, 10, 1810–1819. [Google Scholar] [CrossRef] [PubMed]
  16. Lu, P.J.; Cheng, W.L.; Huang, S.C.; Chen, Y.P.; Chou, H.K.; Cheng, H.F. Characterizing titanium dioxide and zinc oxide nanoparticles in sunscreen spray. Int. J. Cosmet. Sci. 2015, 37, 620–626. [Google Scholar] [CrossRef] [PubMed]
  17. Lu, P.-J.; Huang, S.-C.; Chen, Y.-P.; Chiueh, L.-C.; Shih, D.Y.-C. Analysis of titanium dioxide and zinc oxide nanoparticles in cosmetics. J. Food Drug Anal. 2015, 23, 587–594. [Google Scholar] [CrossRef]
  18. Singh, C.; Friedrichs, S.; Levin, M.; Birkedal, R.; Jensen, K.A.; Pojana, G.; Wohlleben, W.; Schulte, S.; Wiench, K.; Turney, T.; et al. NM-Series of Representative Manufactured Nanomaterials: Zinc Oxide NM-110, NM-111, NM-112, NM-113 Characterisation and Test Item Preparation; European Commission Joint Research Centre Institute for Reference Materials and Measurements - EUR 25066 EN; Publications Office of the European Union: Luxembourg, 2011; ISBN 978-92-79-22215-3. ISSN 1831-9424. [Google Scholar] [CrossRef]
  19. Calixto, L.S.; Maia Campos, P. Physical-Mechanical characterization of cosmetic formulations and correlation between instrumental measurements and sensorial properties. Int. J. Cosmet. Sci. 2017, 39, 527–534. [Google Scholar] [CrossRef]
  20. United States Pharmacopeia (USP). Microbiol. Tests 2017, 40, 117–130.
  21. Pleus, R. Nanotechnologies-Guidance on Physicochemical Characterization of Engineered Nanoscale Materials for Toxicologic Assessment; ISO: Geneva, Switzerland, 2012. [Google Scholar]
  22. Irfan, M.; Moniruzzaman, M.; Ahmad, T.; Mandal, P.C.; Bhattacharjee, S.; Abdullah, B. Ionic liquid based extraction of flavonoids from Elaeis guineensis leaves and their applications for gold nanoparticles synthesis. J. Mol. Liq. 2017, 241, 270–278. [Google Scholar] [CrossRef]
  23. Berg, J.M.; Romoser, A.; Banerjee, N.; Zebda, R.; Sayes, C.M. The relationship between pH and zeta potential of∼ 30 nm metal oxide nanoparticle suspensions relevant to in vitro toxicological evaluations. Nanotoxicology 2009, 3, 276–283. [Google Scholar] [CrossRef]
  24. Leite-Silva, V.R.; Le Lamer, M.; Sanchez, W.Y.; Liu, D.C.; Sanchez, W.H.; Morrow, I.; Martin, D.; Silva, H.D.T.; Prow, T.W.; Grice, J.E.; et al. The effect of formulation on the penetration of coated and uncoated zinc oxide nanoparticles into the viable epidermis of human skin in vivo. Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Fur Pharm. Verfahrenstechnik EV 2013, 84, 297–308. [Google Scholar] [CrossRef] [PubMed]
  25. Dai, S.; Jiang, F.; Corke, H.; Shah, N.P. Physicochemical and textural properties of mozzarella cheese made with konjac glucomannan as a fat replacer. Food Res. Int. 2018, 107, 691–699. [Google Scholar] [CrossRef] [PubMed]
  26. Shakerardekani, A.; Karim, R.; Ghazali, H.M.; Chin, N.L. Development of Pistachio (Pistacia vera L.) spread. J. Food Sci. 2013, 78, S484–S489. [Google Scholar] [CrossRef] [PubMed]
  27. Tamburic, S.; Sisson, H.; Cunningham, N.; Stevic, M. Rheological and texture analysis methods for quantifying yield value and level of thixotropy. SOFW J. 2017, 143, 24–30. [Google Scholar]
  28. Gaspar, L.R.; Maia Campos, P.M. Rheological behavior and the SPF of sunscreens. Int. J. Pharm. 2003, 250, 35–44. [Google Scholar] [CrossRef]
  29. Radočaj, O.; Dimić, E.; Diosady, L.L.; Vujasinović, V. Optimizing the texture attributes of a fat-based spread using instrumental measurements. J. Texture Stud. 2011, 42, 394–403. [Google Scholar] [CrossRef]
  30. Gilbert, L.; Savary, G.; Grisel, M.; Picard, C. Predicting sensory texture properties of cosmetic emulsions by physical measurements. Chemom. Intell. Lab. Syst. 2013, 124, 21–31. [Google Scholar] [CrossRef]
  31. Camargo Junior, F.B. Desenvolvimento de Formulações Cosméticas Contendo Pantenol e Avaliação dos seus Efeitos Hidratantes na pele Humana por Bioengenharia Cutânea. Ph.D. Thesis, Universidade de São Paulo, São Paulo, Brazil, 2006. [Google Scholar]
  32. Martin, A.; Bustamante, P.; Chun, A.H.C. Rheology. Physical Pharmacy; Lea & Febiger, cap. 17: Philadelphia, PA, USA, 1993; pp. 453–473. [Google Scholar]
  33. Leonardi, G.; Maia Campos, P. Estabilidade de formulações cosméticas. Int. J. Pharm. Compd. 2001, 3, 154–156. [Google Scholar]
  34. Rajadhyaksha, M.; Marghoob, A.; Rossi, A.; Halpern, A.C.; Nehal, K.S. Reflectance confocal microscopy of skin in vivo: From bench to bedside. Lasers Surg. Med. 2017, 49, 7–19. [Google Scholar] [CrossRef]
  35. Patzelt, A.; Richter, H.; Knorr, F.; Schäfer, U.; Lehr, C.-M.; Dähne, L.; Sterry, W.; Lademann, J. Selective follicular targeting by modification of the particle sizes. J. Control. Release 2011, 150, 45–48. [Google Scholar] [CrossRef]
  36. Lademann, J.; Richter, H.; Teichmann, A.; Otberg, N.; Blume-Peytavi, U.; Luengo, J.; Weiß, B.; Schaefer, U.F.; Lehr, C.-M.; Wepf, R.; et al. Nanoparticles—An efficient carrier for drug delivery into the hair follicles. Eur. J. Pharm. Biopharm. 2007, 66, 159–164. [Google Scholar] [CrossRef] [PubMed]
Figure 1. SEM and TEM images of the uncoated (A,C) and coated (B,D) ZnOn.
Figure 1. SEM and TEM images of the uncoated (A,C) and coated (B,D) ZnOn.
Cosmetics 11 00006 g001aCosmetics 11 00006 g001bCosmetics 11 00006 g001c
Figure 2. Size distribution histograms by TEM and DLS of the uncoated (A,C) and coated zinc oxide nanoparticles (B,D), respectively.
Figure 2. Size distribution histograms by TEM and DLS of the uncoated (A,C) and coated zinc oxide nanoparticles (B,D), respectively.
Cosmetics 11 00006 g002aCosmetics 11 00006 g002b
Figure 3. Texture parameters of the vehicle (V) and the formulations containing the coated (C) and uncoated (UC) zinc oxide nanoparticles. Different small letters represent differences among the studied formulations in the evaluated texture parameters.
Figure 3. Texture parameters of the vehicle (V) and the formulations containing the coated (C) and uncoated (UC) zinc oxide nanoparticles. Different small letters represent differences among the studied formulations in the evaluated texture parameters.
Cosmetics 11 00006 g003
Figure 4. Hardness parameters of the vehicle (V) and formulations containing the coated (C) and uncoated (UC) zinc oxide nanoparticles. Different small letters represent differences among the studied formulations in the evaluated texture parameters.
Figure 4. Hardness parameters of the vehicle (V) and formulations containing the coated (C) and uncoated (UC) zinc oxide nanoparticles. Different small letters represent differences among the studied formulations in the evaluated texture parameters.
Cosmetics 11 00006 g004
Figure 5. Absorption spectrum of the vehicle and formulations containing the coated and uncoated zinc oxide nanoparticles.
Figure 5. Absorption spectrum of the vehicle and formulations containing the coated and uncoated zinc oxide nanoparticles.
Cosmetics 11 00006 g005
Figure 6. Micrographs of the vehicle at 0 (A) and 90 days (B), of the formulation containing the uncoated ZnOn at 30 (C) and 60 days (D) and of the formulation containing the coated ZnOn at 60 (E) and 90 days (F). Magnification of 20X. Circle (D) and arrows (F) represent the instability signs. The circle represents the instability signs, as described in the Figure legend.
Figure 6. Micrographs of the vehicle at 0 (A) and 90 days (B), of the formulation containing the uncoated ZnOn at 30 (C) and 60 days (D) and of the formulation containing the coated ZnOn at 60 (E) and 90 days (F). Magnification of 20X. Circle (D) and arrows (F) represent the instability signs. The circle represents the instability signs, as described in the Figure legend.
Cosmetics 11 00006 g006
Figure 7. Micrographs of the formulation containing the coated zinc oxide nanoparticles at 90 days. Magnification of 40×. The circle represents the instability signs.
Figure 7. Micrographs of the formulation containing the coated zinc oxide nanoparticles at 90 days. Magnification of 40×. The circle represents the instability signs.
Cosmetics 11 00006 g007
Figure 8. Rheograms of the vehicle (A) and formulations containing the coated (B) and uncoated (C) zinc oxide nanoparticles incubated at 45 °C for 0, 7, 30, 60 and 90 days.
Figure 8. Rheograms of the vehicle (A) and formulations containing the coated (B) and uncoated (C) zinc oxide nanoparticles incubated at 45 °C for 0, 7, 30, 60 and 90 days.
Cosmetics 11 00006 g008
Figure 9. Minimum apparent viscosity and consistency index of the vehicle e and formulations containing the coated (C) or uncoated (UC) ZnOn incubated at 45 °C for 0, 7, 30, 60 and 90 days. Results are presented as mean ± standard error (n = 5). Different letters represent differences among the formulations in the evaluated parameters.
Figure 9. Minimum apparent viscosity and consistency index of the vehicle e and formulations containing the coated (C) or uncoated (UC) ZnOn incubated at 45 °C for 0, 7, 30, 60 and 90 days. Results are presented as mean ± standard error (n = 5). Different letters represent differences among the formulations in the evaluated parameters.
Cosmetics 11 00006 g009
Figure 10. Log of the number of surviving microorganisms, E. coli (A), P. aeruginosa (B), C. albicans (C) and S. aureus (D) as a function of the storage time at room temperature of the vehicle (Cosmetics 11 00006 i001) and formula-tions containing the coated (Cosmetics 11 00006 i002) or uncoated (Cosmetics 11 00006 i003) ZnO nanoparticles.
Figure 10. Log of the number of surviving microorganisms, E. coli (A), P. aeruginosa (B), C. albicans (C) and S. aureus (D) as a function of the storage time at room temperature of the vehicle (Cosmetics 11 00006 i001) and formula-tions containing the coated (Cosmetics 11 00006 i002) or uncoated (Cosmetics 11 00006 i003) ZnO nanoparticles.
Cosmetics 11 00006 g010
Figure 11. RCM images of the stratum corneum (A1,B1,C1,D1), granular layer (A2,B2,C2,D2) and hair/hair follicles (A3,B3,C3,D3) of the porcine skin. A: Non-treated Control; B: Vehicle; C: formulation containing the coated ZnOn; D: formulation containing the uncoated ZnOn. The arrows show the particles accumulation on the skin furrows.
Figure 11. RCM images of the stratum corneum (A1,B1,C1,D1), granular layer (A2,B2,C2,D2) and hair/hair follicles (A3,B3,C3,D3) of the porcine skin. A: Non-treated Control; B: Vehicle; C: formulation containing the coated ZnOn; D: formulation containing the uncoated ZnOn. The arrows show the particles accumulation on the skin furrows.
Cosmetics 11 00006 g011
Table 1. Composition of the formulations containing ZnOn (percentage w/w).
Table 1. Composition of the formulations containing ZnOn (percentage w/w).
ComponentV (%)C (%)UC (%)
Self emulsifying base666
Lanolin333
Caprylic/ Capric Triglycerides666
Butilenglycol333
Glycerin444
Mcllavaine buffer (pH 5.0)q.s.pq.s.pq.s.p
Preservative 10.80.80.8
Preservative 20.250.250.25
Coated ZnOn-20-
Uncoated ZnOn--20
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Assis Dias Alves, G.d.; Cuelho, C.H.F.; Fonseca, M.J.V.; Maia Campos, P.M.B.G. Development of Topical Formulations Containing 20% of Coated and Uncoated Zinc Oxide Nanoparticles: Stability Assessment and Penetration Evaluation by Reflectance Confocal Laser Microscopy. Cosmetics 2024, 11, 6. https://doi.org/10.3390/cosmetics11010006

AMA Style

Assis Dias Alves Gd, Cuelho CHF, Fonseca MJV, Maia Campos PMBG. Development of Topical Formulations Containing 20% of Coated and Uncoated Zinc Oxide Nanoparticles: Stability Assessment and Penetration Evaluation by Reflectance Confocal Laser Microscopy. Cosmetics. 2024; 11(1):6. https://doi.org/10.3390/cosmetics11010006

Chicago/Turabian Style

Assis Dias Alves, Geórgia de, Camila Helena Ferreira Cuelho, Maria José Vieira Fonseca, and Patrícia Maria Berardo Gonçalves Maia Campos. 2024. "Development of Topical Formulations Containing 20% of Coated and Uncoated Zinc Oxide Nanoparticles: Stability Assessment and Penetration Evaluation by Reflectance Confocal Laser Microscopy" Cosmetics 11, no. 1: 6. https://doi.org/10.3390/cosmetics11010006

APA Style

Assis Dias Alves, G. d., Cuelho, C. H. F., Fonseca, M. J. V., & Maia Campos, P. M. B. G. (2024). Development of Topical Formulations Containing 20% of Coated and Uncoated Zinc Oxide Nanoparticles: Stability Assessment and Penetration Evaluation by Reflectance Confocal Laser Microscopy. Cosmetics, 11(1), 6. https://doi.org/10.3390/cosmetics11010006

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop